Abbott Laboratories 2024 AR2
The report highlights Abbott Pakistan's performance in 2024, focusing on its diversified business segments including pharmaceuticals, nutrition, and diagnostics. Key achievements include a 22.9% increase in net sales and significant growth in the diagnostics segment. The company emphasized its commitment to sustainability through initiatives like the 'Zero Waste to Landfill' certification and solar panel installations. It also detailed extensive CSR activities supporting healthcare and education in Pakistan. Furthermore, the report outlines the company's risk management framework and its focus on diversity, equity, and inclusion within its workforce.
Company: Abbott Laboratories
Sector: Industrials
Country: United States
Year: 2024
Type: AR2
Pages: 174
Back to company
Abbott Laboratories
Annual Report
The report highlights Abbott Pakistan's performance in 2024, focusing on its diversified business segments including pharmaceuticals, nutrition, and diagnostics. Key achievements include a 22.9% increase in net sales and significant growth in the diagnostics segment. The company emphasized its commitment to sustainability through initiatives like the 'Zero Waste to Landfill' certification and solar panel installations. It also detailed extensive CSR activities supporting healthcare and education in Pakistan. Furthermore, the report outlines the company's risk management framework and its focus on diversity, equity, and inclusion within its workforce.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Mar 25, 2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees